230 related articles for article (PubMed ID: 9390015)
1. Adaptation of parathyroid function to intravenous 1,25-dihydroxyvitamin D3 or partial parathyroidectomy in normal dogs.
Cloutier M; Gagnon Y; Gascon-Barré M; Brossard JH; D'Amour P
J Endocrinol; 1997 Oct; 155(1):133-41. PubMed ID: 9390015
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
[TBL] [Abstract][Full Text] [Related]
4. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
Brandi L; Egfjord M; Olgaard K
Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
[TBL] [Abstract][Full Text] [Related]
5. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E
Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963
[TBL] [Abstract][Full Text] [Related]
6. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
[TBL] [Abstract][Full Text] [Related]
7. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
[TBL] [Abstract][Full Text] [Related]
8. Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat.
Weisinger JR; Favus MJ; Langman CB; Bushinsky DA
J Bone Miner Res; 1989 Dec; 4(6):929-35. PubMed ID: 2610024
[TBL] [Abstract][Full Text] [Related]
9. Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
Imanishi Y; Inaba M; Seki H; Koyama H; Nishizawa Y; Morii H; Otani S
J Steroid Biochem Mol Biol; 1999; 70(4-6):243-8. PubMed ID: 10622414
[TBL] [Abstract][Full Text] [Related]
10. Lack of involution of hyperplastic parathyroid glands in dogs: adaptation via a decrease in the calcium stimulation set point and a change in secretion profile.
Cloutier M; Brossard JH; Gascon-Barré M; D'Amour P
J Bone Miner Res; 1994 May; 9(5):621-9. PubMed ID: 8053390
[TBL] [Abstract][Full Text] [Related]
11. Low calcium diet in dogs causes a greater increase in parathyroid function measured with an intact hormone than with a carboxylterminal assay.
Cloutier M; D'Amour P; Gascon-Barré M; Hamel L
Bone Miner; 1990 Jun; 9(3):179-88. PubMed ID: 2114188
[TBL] [Abstract][Full Text] [Related]
12. Lack of influence of 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion from normal or hyperplastic glands.
Rothstein M; Olgaard K; Arbelaez M; Finco D; Klahr S; Slatopolsky E
Calcif Tissue Int; 1983 Jul; 35(4-5):449-54. PubMed ID: 6604566
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
14. Immunological evidences for post-translational control of the parathyroid function by ionized calcium in dogs.
Cloutier M; Rousseau L; Gascon-Barré M; D'Amour P
Bone Miner; 1993 Sep; 22(3):197-207. PubMed ID: 8268753
[TBL] [Abstract][Full Text] [Related]
15. Functional evidence for two types of parathyroid adenoma.
D'Amour P; Weisnagel J; Brossard JH; Ste-Marie LG; Rousseau L; Lepage R
Clin Endocrinol (Oxf); 1998 May; 48(5):593-601. PubMed ID: 9666871
[TBL] [Abstract][Full Text] [Related]
16. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
17. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
18. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia.
Funahashi H; Tanaka Y; Imai T; Wada M; Tsukamura K; Hayakawa Y; Matsuura N; Kikumori T; Oiwa M; Tominaga Y; Takagi H
J Endocrinol Invest; 1998 Jan; 21(1):43-7. PubMed ID: 9633022
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture.
Cantley LK; Russell J; Lettieri D; Sherwood LM
Endocrinology; 1985 Nov; 117(5):2114-9. PubMed ID: 3840080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
